Nancey Stéphane, Holvöet Sébastien, Graber Ivan, Joubert Grégoire, Philippe David, Martin Stefan, Nicolas Jean-François, Desreumaux Pierre, Flourié Bernard, Kaiserlian Dominique
INSERM U 404 Immunité et Vaccination, CERVI, IFR 128 Biosciences Lyon-Gerland, Lyon, F-69007, France.
Gastroenterology. 2006 Aug;131(2):485-96. doi: 10.1053/j.gastro.2006.05.018.
BACKGROUND & AIMS: Most mouse models of IBD have emphasized an effector role of type-1 CD4+ T cells in colitis. The aim of this study was to develop a model of antigen-specific relapsing colitis to investigate the relative contribution of CD4+ and CD8+ effectors.
Balb/C mice were sensitized and challenged with a suboptimal dose of 2.4 dinitrobenzene sulfonic acid to generate a colonic delayed-type hypersensitivity response. The respective role of CD4+ and CD8+ T cells in the initiation of colitis was analyzed by in vivo monoclonal antibody depletion and cell-transfer experiments. Dynamic and function of the colitogenic effectors were studied by immunohistochemistry, fluorescence-activated cell sorter analysis, enzyme-linked immunospot assay, quantitative polymerase chain reaction, and in vivo CTL assays.
Relapsing colitis rapidly occurred only after challenge of previously sensitized mice. Interferon-gamma-producing cytotoxic CD8+ T cells (Tc1) specific for hapten-modified self-proteins were generated in colon-draining lymph nodes on day 5 after sensitization, before the onset of disease. These CD8+ T cells were rapidly recruited upon challenge into colon lamina propria as granzyme B-expressing effectors exerting ex vivo cytotoxicity against syngeneic hapten-modified colonic epithelial cells. Colitis was prevented by in vivo antibody depletion of CD8+, but not of CD4+, T cells and could be induced in naive recipients within 48 hours after transfer of CD8+, but not CD4+, T cells purified from sensitized mice.
Our data show that antigen-specific CD8+ T cells can induce relapsing colitis in normal mice and suggest that the cytolytic function of CD8 Tc1 against epithelial cells may initiate the intestinal inflammatory process.
大多数炎症性肠病(IBD)小鼠模型都强调1型CD4 + T细胞在结肠炎中的效应作用。本研究的目的是建立一种抗原特异性复发性结肠炎模型,以研究CD4 +和CD8 +效应细胞的相对贡献。
用次优剂量的2,4-二硝基苯磺酸对Balb/C小鼠进行致敏和激发,以产生结肠迟发型超敏反应。通过体内单克隆抗体清除和细胞转移实验分析CD4 +和CD8 + T细胞在结肠炎起始中的各自作用。通过免疫组织化学、荧光激活细胞分选分析、酶联免疫斑点测定、定量聚合酶链反应和体内细胞毒性T淋巴细胞(CTL)测定来研究致结肠炎效应细胞的动态和功能。
仅在对先前致敏的小鼠进行激发后才迅速发生复发性结肠炎。在致敏后第5天,即在疾病发作之前,在引流结肠的淋巴结中产生了对半抗原修饰的自身蛋白特异的产生γ干扰素的细胞毒性CD8 + T细胞(Tc1)。在激发后,这些CD8 + T细胞作为表达颗粒酶B的效应细胞迅速募集到结肠固有层,对同基因半抗原修饰的结肠上皮细胞发挥体外细胞毒性作用。通过体内抗体清除CD8 +而不是CD4 + T细胞可预防结肠炎,并且在从致敏小鼠中纯化的CD8 +而不是CD4 + T细胞转移后48小时内可在未致敏的受体中诱导结肠炎。
我们的数据表明,抗原特异性CD8 + T细胞可在正常小鼠中诱导复发性结肠炎,并提示CD8 Tc1对上皮细胞的溶细胞功能可能启动肠道炎症过程。